Related Experiment Video
Updated: Oct 25, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Potential Prophylactic Treatments for COVID-19.
Noam Ben-Zuk1, Ido-David Dechtman2,3, Itai Henn1
1Chemical, Biological, Radiological and Nuclear Defense Division, Ministry of Defense, HaKirya, Tel-Aviv 61909, Israel.
This review examines small-molecule drugs for preventing Coronavirus Disease 2019 (COVID-19). It identifies potential prophylactic medications, including antivirals and repurposed drugs, to address limited vaccine availability.
Area of Science:
- Virology
- Pharmacology
- Public Health
Background:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes COVID-19, a global pandemic with varying disease severity.
- Limited worldwide vaccine availability necessitates additional countermeasures against SARS-CoV-2.
- Small-molecule drugs offer potential for accessible, safe, scalable, and affordable COVID-19 prophylaxis.
Purpose of the Study:
- To review and categorize potential small-molecule prophylactic drugs for COVID-19.
- To consolidate a list of candidate medications, including antivirals, repurposed drugs, and miscellaneous agents.
- To provide a molecular/clinical background, safety profile, and current research status for each drug.
Main Methods:
- Comprehensive screening of clinical trials for relevant small-molecule candidates.
- Categorization of drugs into antivirals, repurposed drugs, or miscellaneous.
- Review of molecular/clinical background, safety, and COVID-19 relevance for each drug.
Main Results:
- Identified and categorized various small-molecule candidates for COVID-19 prophylaxis.
- Provided rationales for prophylactic use, discussing antiviral or anti-inflammatory mechanisms.
- Reviewed drug safety profiles, current indications, and research status for COVID-19.
Conclusions:
- Small-molecule drugs are crucial for accessible COVID-19 prophylaxis due to limited vaccine availability.
- Further research and clinical data are expected to clarify the efficacy of these prophylactic treatments.
- This review consolidates information on potential drug candidates, aiding future research and countermeasure development.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Preventive Healthcare Services
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...

